Rudra Shares and Stock Brokers LTD.
ABOUT US | CONTACT US| CAREER
BACKOFFICE LOGIN
INDIA INX Global
  ONLINE TRADING
search
Equity

COMPANY NEWS

Cipla LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:500087
ISIN Demat:INE059A01026
Book Value(Rs):320.5640364
NSE Symbol:CIPLA
Div & Yield %:0.6
Market Cap (Rs Cr.):113794.25
P/E(TTM):34.6
EPS(TTM):40.73
Face Value(Rs):2
  Change Company 
Cipla Jiangsu facility clear USFDA inspection
(02 Mar 2024)
Cipla (Jiangsu) Pharmaceutical Co. is a subsidiary of the company. The inspection has been concluded with zero Form 483 observations, stated the drug maker.

Meanwhile, the pharma company stated that the joint venture (JV) agreement entered between Cipla (EU) (wholly owned subsidiary of the company in UK) with Kemwell Biopharma UK and MNI Ventures have received confirmation of incorporation of JV ‘MKC Biotherapeutics Inc.’ from Secretary of State, Delaware, USA on 29 February 2024. The effective date of incorporation is 27 February 2024.

Further, Cipla informed that it has completed the transfer of Generics Business Undertaking as a going concern on a slump sale basis to Cipla Pharma and Life Sciences, a wholly owned subsidiary of the Company on 1 March 2024.

Cipla is a global pharmaceutical company focused on agile and sustainable growth, complex generics, and deepening portfolio in our home markets of India, South Africa, North America, and key regulated and emerging markets.

The pharmaceutical company reported 31.82% increase in consolidated net profit to Rs 1,055.90 crore on 13.53% rise in revenue from operations to Rs 6,505.66 crore in Q3 FY24 over Q3 FY23.

The scrip rose 0.85% to currently trade at Rs 1,483.15 on the BSE.

ATTENTION INVESTORS : Prevent unauthorised transactions in your account Update your mobile numbers / email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile / email at the end of the day .... Issued in the interest of Investors.    ||     Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.   ||    KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
Attention Investors

1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020

2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on
your email id and/or mobile number to create pledge.

3. Pay 20% upfront margin of the transaction value to trade in cash market segment.

4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191
dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.

(Issued in the interest of Investors.)

Important Message

This is to inform that, many instances were reported by general public where fraudsters are cheating general public by misusing our brand name RUDRA SHARES.
The fraudsters are luring the general public to transfer them money by falsely committing attractive brokerage / investment schemes of share market and/or Mutual Funds
and/or personal loan facilities. Though as for as possible, we initiate legal actions against the fraudsters, we request you to not fall prey to such fraudsters. You can check
about our products and services by visiting our website www.rudrashares.com. You can also write to us at compliance@rudrashares.com, to know more about products and services.

SEBI REGN. (STOCK BROKER) - NSE-CM/FO/CD / BSE-CM/FO/CD / MCX / NCDEX - INZ000004937
SEBI REGN. (DP)IN-DP-558-2021
@ 2015. ALL RIGHTS RESERVED. RUDRA SHARES & STOCK BROKERS LTD.
Designed, developed and powered by C-MOTS Infotech (ISO 9001:2015 certified)